Cargando…
COVID-19 Vaccines (Revisited) and Oral-Mucosal Vector System as a Potential Vaccine Platform
There are several emerging strategies for the vaccination of COVID-19 (SARS-CoV-2) however, only a few have yet shown promising effects. Thus, choosing the right pathway and the best prophylactic options in preventing COVID-19 is still challenging at best. Approximately, more than two-hundred vaccin...
Autores principales: | Ashraf, Muhammad Umer, Kim, Yeji, Kumar, Sunil, Seo, Dongyeob, Ashraf, Maryam, Bae, Yong-Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922043/ https://www.ncbi.nlm.nih.gov/pubmed/33670630 http://dx.doi.org/10.3390/vaccines9020171 |
Ejemplares similares
-
Immunotherapeutic Potential of m6A-Modifiers and MicroRNAs in Controlling Acute Myeloid Leukaemia
por: Kumar, Sunil, et al.
Publicado: (2021) -
Dendritic Cell-Mediated Th2 Immunity and Immune Disorders
por: Kumar, Sunil, et al.
Publicado: (2019) -
Live-Attenuated Bacterial Vectors for Delivery of Mucosal Vaccines, DNA Vaccines, and Cancer Immunotherapy
por: Kumar, Sudeep
Publicado: (2019) -
Adenoviruses as vectors for delivering vaccines to mucosal surfaces
por: Babiuk, L.A, et al.
Publicado: (2000) -
Mucosal Immune System and M Cell-targeting Strategies for Oral Mucosal Vaccination
por: Kim, Sae-Hae, et al.
Publicado: (2012)